8-K: WM Technology Reports Q1 2026 Results

WM Technology announced its first quarter 2026 financial results, reporting $43.6 million in revenue and $1.7 million in net income, while sustaining Adjusted EBITDA profitability.

Summary

• WM Technology reported first quarter 2026 revenue of $43.6 million, a slight decrease from $44.6 million in the prior year period, attributed to softness in core markets impacting advertising spend.
• Net income for the quarter was $1.7 million, down from $2.5 million in the first quarter of 2025.
• Adjusted EBITDA decreased to $5.9 million from $10.1 million in the prior year period.
• Average monthly paying clients decreased to 4,983 from 5,179 year-over-year, mainly due to churn in established markets, though this was partially offset by new client acquisitions.
• Average monthly revenue per paying client increased to $2,914 from $2,871, driven by a positive mix shift from lower-spending clients churning.
• The company ended the quarter with $57.0 million in cash, cash equivalents, and marketable securities, an increase from $53.3 million in the prior year.
• WM Technology expects second quarter 2026 revenue to decline by low-single digit percentages sequentially.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to declining revenues, net income, and Adjusted EBITDA, alongside a decrease in paying clients, despite some positive operational metrics and forward-looking optimism regarding cannabis rescheduling.

Positives

• Sustained consecutive quarters of Adjusted EBITDA profitability.
• Average monthly revenue per paying client increased to $2,914 from $2,871, indicating improved monetization from remaining clients.
• Cash, cash equivalents, and marketable securities increased to $57.0 million as of March 31, 2026, up from $53.3 million as of March 31, 2025, providing financial flexibility.
• The CEO expressed optimism regarding the rescheduling of medical cannabis, viewing it as a constructive federal step forward for the industry.

Negatives

• Revenue for the first quarter decreased to $43.6 million from $44.6 million in the prior year period.
• Net income decreased to $1.7 million from $2.5 million in the prior year period.
• Adjusted EBITDA decreased significantly to $5.9 million from $10.1 million in the prior year period.
• Average monthly paying clients decreased to 4,983 from 5,179 year-over-year, indicating a reduction in the client base.
• The company expects second quarter 2026 revenue to decline by low-single digit percentages sequentially.

Risks

• Continued softness across core markets and challenging operating conditions for cannabis operators weighing on advertising spend.
• Churn in more established markets impacting the number of average monthly paying clients.
• Potential for material variations from revenue guidance due to various factors.
• Risks associated with the company's delisting from Nasdaq and deregistration under Section 12(b) of the Exchange Act, including impacts on liquidity and stock price.
• The possibility of significantly less liquidity and/or greater price volatility in trading on OTC markets.
• The company's ability to remediate material weaknesses in internal controls.
• Changes in laws and regulations, particularly concerning the cannabis and hemp industries.
• Cyber-attacks and security vulnerabilities.

Future Outlook

The company expects second quarter 2026 revenue to decline by low-single digit percentages sequentially from the first quarter. This guidance assumes no business acquisitions, investments, restructurings, or legal settlements are concluded in the period.

Management Comments

• "We are encouraged by the recent rescheduling of medical cannabis, which represents a meaningful federal step forward for the industry and for the millions of patients who rely on medical cannabis," said Doug Francis, CEO and Chairman of WM Technology.
• "While the full impact of this change will take time to unfold, including how it may affect our business and the broader cannabis ecosystem and adult-use markets, we view any federal progress as constructive."
• "We are pairing that long-term optimism with disciplined execution across the business by investing in product enhancements, sharpening our go-to-market efforts, and continuing to build a stronger marketplace for clients and consumers."
• "Our first quarter results reflected steady execution, with revenue coming in ahead of our guidance range," said Susan Echard, CFO of WM Technology.
• "We remain focused on disciplined expense and working capital management, aligning our cost structure with the current operating environment, and maintaining the financial flexibility needed to support the business and invest selectively against our long-term priorities."

Industry Context

StockSavvy.ai notes that WM Technology's results are being reported amidst ongoing federal discussions and actions regarding cannabis rescheduling, which the company views as a positive development. However, the company's performance is currently impacted by 'softness across core markets' and 'challenging operating conditions for cannabis operators,' suggesting broader industry headwinds affecting advertising spend.

Legal Proceedings

• Ongoing litigation related to shareholder derivative actions.

Stakeholder Impact

• Shareholders may be impacted by the decrease in revenue, net income, and Adjusted EBITDA, as well as the expected sequential revenue decline.
• Clients may face challenges due to market softness, potentially impacting their advertising spend and engagement with the platform.
• Employees may be affected by the company's focus on disciplined expense management and alignment of cost structure with the operating environment.

Next Steps

• Continue investing in product enhancements.
• Sharpen go-to-market efforts.
• Build a stronger marketplace for clients and consumers.
• Maintain disciplined expense and working capital management.
• Invest selectively against long-term priorities.
• Host investor conference call and webcast on May 11, 2026.

Key Dates

Recommendation

While the company shows resilience in maintaining Adjusted EBITDA profitability and increasing average revenue per client, the overall decline in key financial metrics (revenue, net income, EBITDA) and the forecast for sequential revenue decline suggest caution. The positive outlook on cannabis rescheduling is a long-term factor, but current operational challenges and reduced client numbers warrant a 'hold' recommendation until performance trends improve.

Keywords

WM Technology, Weedmaps, Cannabis Industry, Financial Results, Q1 2026, Revenue, Adjusted EBITDA, Marketplace